Exhibit 99.1




Ideal Power Reports First Quarter 2022 Financial Results


AUSTIN, TX – May 16, 2022 -- Ideal Power Inc. (“Ideal Power” or the “Company”) (Nasdaq: IPWR), pioneering the development and commercialization of the highly efficient and broadly patented B-TRAN™ bidirectional semiconductor power switch, reported results for its first quarter ended March 31, 2022.


“Since the year began, we made strong advancements along our 2022 roadmap to commercialize B-TRAN™ as an innovative technology that we believe can disrupt high-growth markets by solving immediate power control application needs. We added several commercial businesses to our test and evaluation program and, in collaboration with Diversified Technologies, Inc. (DTI), we completed our project commitments under the Small Business Innovation Research (SBIR) Phase I grant with the Department of Energy (DOE) to demonstrate a 13.8 kV alternating current (AC) solid-state circuit breaker (SSCB). We also qualified a second domestic semiconductor fabrication partner, began the qualification process of a non-domestic fabricator for high-volume production, and completed trial mechanical builds at a world-class packaging firm. In all, it is a strong start to the year and our momentum continues toward our objective to introduce our first commercial product by year end,” stated Dan Brdar, President and Chief Executive Officer of Ideal Power.


Key First Quarter and Recent Operational Highlights


·Added participants to the B-TRAN™ test and evaluation program, including:


oa leading manufacturer of commercial electric vehicles (EVs), EV powertrain components and EV charging infrastructure for use in power conversion applications in its commercial EVs;


oa Fortune 1000 global semiconductor manufacturer interested in evaluating B-TRAN™ for its low losses and bidirectional capability;


oa space applications systems developer interested in evaluating B-TRAN™ for use in SSCBs; and


oan aerospace and defense systems integrator, also interested in evaluating B-TRAN™ for use in SSCBs, with whom Ideal Power is jointly pursuing additional government grants.


·Delivered on the Company’s project commitments under the SBIR Phase I grant won in collaboration with DTI from the DOE to develop a B-TRAN™-driven low-loss 13.8 kV AC SSCB. DTI submitted, in collaboration with Ideal Power, an SBIR Phase II proposal to demonstrate a 13.8 kV AC SSCB. If awarded a Phase II grant by the DOE, DTI will build and test a full 50 MW AC SSCB using Ideal Power B-TRAN™ devices.


·Submitted several proposals and concept papers for government funding opportunities, including proposals with three new partners.


·Under the Naval Sea Systems Command program, initial wafers from the latest fabrication run are ready for dicing and packaging, which will be followed by device testing. Ideal Power will continue to provide program support through the demonstration of the B-TRAN™ enabled direct current SSCB later this year.





·Completed the qualification of a second domestic semiconductor fabrication partner that brings bipolar fabrication experience, supporting ongoing development activities.


·Began the qualification of a non-domestic fabrication partner for higher volume production. This fabricator has begun short loops, or limited process production test steps. If the short loops are successful, the next step would be a full process flow engineering run later this year.


·Ideal Power’s world-class packaging partner has completed design work as well as trial mechanical builds and will soon be packaging its first devices in preparation for anticipated volume production.


·Completed a pilot run with domestic packaging firm.


·B-TRAN™ Patent Estate: Currently have 67 issued B-TRAN™ patents with 29 of those issued outside of the United States and 25 pending B-TRAN™ patents. In April, Ideal Power was issued its first patent in India. Geographic coverage of the patent portfolio now includes North America, China, Japan, South Korea, India and Europe.


First Quarter and 2022 Financial Results


·Grant revenue was $125,008 in the first quarter of 2022 compared to $242,061 in the first quarter of 2021.


·Operating expenses in the first quarter of 2022 were $1.9 million compared to $0.9 million in the first quarter of 2021 on higher research and development, sales and marketing and general and administrative expenses.


·Net loss in the first quarter of 2022 was $1.9 million compared to $0.9 million in the first quarter of 2021.


·Cash used in operating and investing activities in first quarter 2022 was $1.4 million compared to $1.3 million in the fourth quarter of 2021 and $0.8 million in first quarter 2021.


·Cash and cash equivalents totaled $21.7 million at March 31, 2022.


·Ideal Power had no long-term debt outstanding at March 31, 2022.


First Quarter 2022 Conference Call Details


Ideal Power President and CEO Dan Brdar and CFO Tim Burns will host a conference call today, followed by a question-and-answer period.


To access the call, please use the following information:


Date: Monday, May 16, 2022
Time: 4:30 p.m. EDT, 1:30 p.m. PDT
Toll-free dial-in number: 1-888-204-4368
International dial-in number: 1-323-994-2093
Conference ID: 5156822





Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact LHA Investor Relations at 1-212-838-3777.


The conference call will be broadcast live and available for replay at https://event.choruscall.com/mediaframe/webcast.html?webcastid=Irt8jYYS via the investor relations section of the Company’s website at www.IdealPower.com.


A replay of the conference call will be available after 7:30 p.m. Eastern time on Monday, May 16, 2022 through Thursday, June 16, 2022.


Toll Free Replay Number: 1-844-512-2921
International Replay Number: 1-412-317-6671
Replay ID: 5156822


About Ideal Power Inc.


Ideal Power (NASDAQ: IPWR) is pioneering the development of its broadly patented bidirectional semiconductor power switch, creating highly efficient and ecofriendly energy control solutions for electric vehicle, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The Company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN™) semiconductor technology. B-TRAN™ is a unique double-sided bidirectional AC switch able to deliver substantial performance improvements over today's conventional power semiconductors. Ideal Power believes B-TRAN™ will reduce conduction and switching losses, complexity of thermal management and operating cost in medium voltage AC power switching and control circuitry. For more information, visit www.IdealPower.com.


Safe Harbor Statement


All statements in this release that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While Ideal Power’s management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Such forward-looking statements include, but are not limited to, statements regarding our belief that B-TRAN™ can disrupt high-growth markets by solving immediate power control application needs, our plan to introduce our first commercial product by year end and our plans to continue to provide program support through the demonstration of the B-TRAN™ enabled DC SSCB later this year. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties and other factors, many of which are outside of our control that could cause actual results to materially differ from such statements. Such risks, uncertainties, and other factors include, but are not limited to, the impact of COVID-19 on our business, financial condition and results of operations, the success of our B-TRAN™ technology, including whether the patents for our technology provide adequate protection and whether we can be successful in maintaining, enforcing and defending our patents and our inability to predict with precision or certainty the pace and timing of development and commercialization of our B-TRAN™ technology, including the timing of the completion of our wafer fabrication runs with our semiconductor fabrications partners and our continued success engaging companies to participate in our customer sampling program, and uncertainties set forth in our quarterly, annual and other reports filed with the Securities and Exchange Commission. Furthermore, we operate in a highly competitive and rapidly changing environment where new and unanticipated risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. We disclaim any intention to, and undertake no obligation to, update or revise forward-looking statements.


Ideal Power Investor Relations Contact:


LHA Investor Relations 

Carolyn Capaccio, CFA

T: 212-838-3777







Balance Sheets



   March 31,   December 31, 
   2022   2021 
Current assets:          
Cash and cash equivalents  $21,725,410   $23,170,149 
Accounts receivable, net   262,137    233,262 
Prepayments and other current assets   120,906    43,900 
Total current assets   22,108,453    23,447,311 
Property and equipment, net   59,811    56,158 
Intangible assets, net   2,035,423    2,055,650 
Right of use asset   292,887    307,172 
Other assets   11,189    11,189 
Total assets  $24,507,763   $25,877,480 
Current liabilities:          
Accounts payable  $380,033   $130,500 
Accrued expenses   315,785    353,507 
Current portion of lease liability   60,265    58,864 
Total current liabilities   756,083    542,871 
Long-term lease liability   252,092    267,584 
Other long-term liabilities   922,439    917,100 
Total liabilities   1,930,614    1,727,555 
Commitments and contingencies          
Stockholders’ equity:          
Common stock, $0.001 par value; 50,000,000 shares authorized; 5,905,118 shares issued and 5,903,797 shares outstanding at March 31, 2022 and 5,893,767 shares issued and 5,892,446 shares outstanding at December 31, 2021   5,905    5,894 
Additional paid-in capital   104,395,175    104,063,321 
Treasury stock, at cost, 1,321 shares at March 31, 2022 and December 31, 2021   (13,210)   (13,210)
Accumulated deficit   (81,810,721)   (79,906,080)
Total stockholders’ equity   22,577,149    24,149,925 
Total liabilities and stockholders’ equity  $24,507,763   $25,877,480 






Statements of Operations 



   Three Months Ended 
   March 31, 
   2022   2021 
Grant revenue  $125,008   $242,061 
Cost of grant revenue   125,008    242,061 
Gross profit        
Operating expenses:          
Research and development   828,547    260,880 
General and administrative   852,949    600,686 
Sales and marketing   219,429    62,578 
Total operating expenses   1,900,925    924,144 
Loss from operations   (1,900,925)   (924,144)
Interest expense, net   (3,716)   (6)
Net loss  $(1,904,641)  $(924,150)
Net loss per share – basic and diluted  $(0.31)  $(0.17)
Weighted average number of shares outstanding – basic and diluted   6,155,352    5,344,025 






Statements of Cash Flows 



   Three Months Ended 
   March 31, 
   2022   2021 
Cash flows from operating activities:          
Net loss  $(1,904,641)  $(924,150)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   44,190    29,515 
Stock-based compensation   231,765    61,933 
Stock issued for services   100,100    68,680 
Decrease (increase) in operating assets:          
Accounts receivable   (28,875)   44,400 
Prepaid expenses and other assets   (62,721)   (17,715)
Increase (decrease) in operating liabilities:          
Accounts payable   249,533    5,306 
Accrued expenses   (46,474)   (111,306)
Net cash used in operating activities   (1,417,123)   (843,337)
Cash flows from investing activities:          
Purchase of property and equipment   (11,031)   (1,462)
Acquisition of intangible assets   (16,585)   (29,275)
Net cash used in investing activities   (27,616)   (30,737)
Cash flows from financing activities:          
Net proceeds from issuance of common stock       21,204,609 
Exercise of options and warrants       3,301,226 
Net cash provided by financing activities       24,505,835 
Net increase (decrease) in cash and cash equivalents   (1,444,739)   23,631,761 
Cash and cash equivalents at beginning of period   23,170,149    3,157,256 
Cash and cash equivalents at end of period  $21,725,410   $26,789,017